defibrotide for the treatment of severe hepatic veno-cc*
$366,742R01FY2007FDFDA
Dana-Farber Cancer Inst, Boston MA
Investigators
Abstract
Abstract Not Provided
View original record on NIH RePORTER →Dana-Farber Cancer Inst, Boston MA
Abstract Not Provided
View original record on NIH RePORTER →